Literature DB >> 20577711

MKR mice have increased dynamic glucose disposal despite metabolic inflexibility, and hepatic and peripheral insulin insensitivity.

B Vaitheesvaran1, D LeRoith, I J Kurland.   

Abstract

AIMS/HYPOTHESIS: Recent work has shown that there can be significant differences when glucose disposal is assessed for high-fat induced insulin resistance by static clamp methods vs dynamic assessment during a stable isotope i.p. glucose tolerance test. MKR mice, though lean, have severe insulin resistance and decreased muscle fatty acid oxidation. Our goal was to assess dynamic vs static glucose disposal in MKR mice, and to correlate glucose disposal and muscle-adipose-liver flux interactions with metabolic flexibility (indirect calorimetry) and muscle characteristics.
METHODS: Stable isotope flux phenotyping was performed using [6,6-(2)H(2)]glucose, [U-(13)C(6)]glucose and [2-(13)C]glycerol. Muscle triacylglycerol (TAG) and diacylglycerol (DAG) content was assessed by thin layer chromatography, and histological determination of fibre type and cytochrome c activity performed. Metabolic flexibility was assessed by indirect calorimetry.
RESULTS: Indirect calorimetry showed that MKR mice used more glucose than FVB/N mice during fasting (respiratory exchange ratio [RER] 0.88 vs 0.77, respectively). Compared with FVB/N mice, MKR mice had faster dynamic glucose disposal, despite increased whole-muscle DAG and TAG, and similar hepatic glucose production with higher fasting insulin and unchanged basal glucose. Fed MKR muscle had more glycogen, and increased levels of GLUT1 and GLUT4 than FVB/N muscle. Histology indicated that MKR soleus had mildly decreased cytochrome c activity overall and more type II (glycolytic) fibres compared with that in FVB/N mice. CONCLUSIONS/
INTERPRETATION: MKR muscle adapts to using glucose, with more type II fibres present in red muscle. Fasting RER is elevated and glucose disposal during an i.p. glucose tolerance test is accelerated despite increased muscle DAG and TAG. Metabolic inflexibility may result from the compensatory use of fuel that can be best utilised for energy requirements; static vs dynamic glucose disposal assessments may measure complementary aspects of metabolic flexibility and insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20577711      PMCID: PMC5322278          DOI: 10.1007/s00125-010-1827-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  20 in total

1.  Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes.

Authors:  Z Asghar; D Yau; F Chan; D Leroith; C B Chan; M B Wheeler
Journal:  Diabetologia       Date:  2005-12-15       Impact factor: 10.122

2.  Advantages of dynamic "closed loop" stable isotope flux phenotyping over static "open loop" clamps in detecting silent genetic and dietary phenotypes.

Authors:  Bhavapriya Vaitheesvaran; Fu-Yu Chueh; Jun Xu; Chuck Trujillo; M F Saad; W N P Lee; Owen P McGuinness; Irwin J Kurland
Journal:  Metabolomics       Date:  2009-11-12       Impact factor: 4.290

3.  Determination of a glucose-dependent futile recycling rate constant from an intraperitoneal glucose tolerance test.

Authors:  Jun Xu; W N Paul Lee; Gary Xiao; Chuck Trujillo; Vicky Chang; Lilia Blanco; Felicia Hernandez; Beau Chung; Sahar Makabi; Sayed Ahmed; Sara Bassilian; Mohammed Saad; Irwin J Kurland
Journal:  Anal Biochem       Date:  2003-04-15       Impact factor: 3.365

4.  A quick, simple and reliable histochemical method for ATPase in human muscle preparations.

Authors:  J M Round; Y Matthews; D A Jones
Journal:  Histochem J       Date:  1980-11

5.  MKR mice are resistant to the metabolic actions of both insulin and adiponectin: discordance between insulin resistance and adiponectin responsiveness.

Authors:  Chul-Hee Kim; Patricia Pennisi; Hong Zhao; Shoshana Yakar; Jeanne B Kaufman; Kenjiro Iganaki; Joseph Shiloach; Philipp E Scherer; Michael J Quon; Derek LeRoith
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-02-28       Impact factor: 4.310

6.  Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes.

Authors:  H Kim; M Haluzik; O Gavrilova; S Yakar; J Portas; H Sun; U B Pajvani; P E Scherer; D LeRoith
Journal:  Diabetologia       Date:  2004-12-15       Impact factor: 10.122

7.  Decreased hepatic futile cycling compensates for increased glucose disposal in the Pten heterodeficient mouse.

Authors:  Jun Xu; Lori Gowen; Christian Raphalides; Katrina K Hoyer; Jason G Weinger; Mathilde Renard; Joshua J Troke; Bhavapriya Vaitheesyaran; W N Paul Lee; Mohammed F Saad; Mark W Sleeman; Michael A Teitell; Irwin J Kurland
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

8.  Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production.

Authors:  Jun Xu; Gary Xiao; Chuck Trujillo; Vicky Chang; Lilia Blanco; Sean B Joseph; Sara Bassilian; Mohammed F Saad; Peter Tontonoz; W N Paul Lee; Irwin J Kurland
Journal:  J Biol Chem       Date:  2002-08-09       Impact factor: 5.157

9.  Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice.

Authors:  Lisa Héron-Milhavet; Martin Haluzik; Shoshana Yakar; Oksana Gavrilova; Stephanie Pack; William C Jou; Azeddine Ibrahimi; Hyunsook Kim; Desmond Hunt; Daphne Yau; Zeenat Asghar; Jamie Joseph; Michael B Wheeler; Nada A Abumrad; Derek LeRoith
Journal:  Endocrinology       Date:  2004-07-01       Impact factor: 4.736

10.  Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus.

Authors:  Patricia Pennisi; Oksana Gavrilova; Jennifer Setser-Portas; William Jou; Stefania Santopietro; David Clemmons; Shoshana Yakar; Derek LeRoith
Journal:  Endocrinology       Date:  2006-03-02       Impact factor: 4.736

View more
  18 in total

1.  Re-patterning of skeletal muscle energy metabolism by fat storage-inducing transmembrane protein 2.

Authors:  Diego A Miranda; Timothy R Koves; David A Gross; Alexandra Chadt; Hadi Al-Hasani; Gary W Cline; Gary J Schwartz; Deborah M Muoio; David L Silver
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

2.  Role of the tumor suppressor IQGAP2 in metabolic homeostasis: Possible link between diabetes and cancer.

Authors:  B Vaitheesvaran; K Hartil; A Navare; P OBroin; A Golden; Wn Lee; I J Kurland; J E Bruce
Journal:  Metabolomics       Date:  2014-10-01       Impact factor: 4.290

3.  Dynamic Glucose Disposal is Driven by Reduced Endogenous Glucose Production in Response to Voluntary Wheel Running: A Stable Isotope Approach.

Authors:  Timothy D Allerton; Greg Kowalski; Hardy Hang; Jacqueline Stephens
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-04-28       Impact factor: 4.310

Review 4.  Multifaceted role of insulin-like growth factors and mammalian target of rapamycin in skeletal muscle.

Authors:  Robert A Frost; Charles H Lang
Journal:  Endocrinol Metab Clin North Am       Date:  2012-05-10       Impact factor: 4.741

5.  Differential Role of Insulin/IGF-1 Receptor Signaling in Muscle Growth and Glucose Homeostasis.

Authors:  Brian T O'Neill; Hans P M M Lauritzen; Michael F Hirshman; Graham Smyth; Laurie J Goodyear; C Ronald Kahn
Journal:  Cell Rep       Date:  2015-05-14       Impact factor: 9.423

Review 6.  A review of rodent models of type 2 diabetic skeletal fragility.

Authors:  Roberto J Fajardo; Lamya Karim; Virginia I Calley; Mary L Bouxsein
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

7.  Polyol accumulation in muscle and liver in a mouse model of type 2 diabetes.

Authors:  Emily J Gallagher; Derek LeRoith; Marilyn Stasinopoulos; Zara Zelenko; Joseph Shiloach
Journal:  J Diabetes Complications       Date:  2016-04-27       Impact factor: 2.852

8.  Hexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in Nonobese Insulin-Resistant Male MKR Mice.

Authors:  Rasha Mosa; Lili Huang; Yeda Wu; Chungyan Fung; Oshini Mallawakankanamalage; Derek LeRoith; Chen Chen
Journal:  Endocrinology       Date:  2017-10-01       Impact factor: 4.736

9.  Peripheral effects of FAAH deficiency on fuel and energy homeostasis: role of dysregulated lysine acetylation.

Authors:  Bhavapriya Vaitheesvaran; Li Yang; Kirsten Hartil; Sherrye Glaser; Stephen Yazulla; James E Bruce; Irwin J Kurland
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

10.  The beta-3 adrenergic agonist (CL-316,243) restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice.

Authors:  Amit Kumar; Joseph Shiloach; Michael J Betenbaugh; Emily J Gallagher
Journal:  Nutr Metab (Lond)       Date:  2015-03-08       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.